Does the prophylactic use of Palivizumab in premature patients with Down Syndrome in respiratory syncytial virus infection reduce the hospitalization rate? An integrative review. Research, Society and Development, [S. l.], v. 13, n. 1, p. e13513144288, 2024. DOI: 10.33448/rsd-v13i1.44288. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/44288. Acesso em: 28 jun. 2025.